sexual dysfunction

This page shows the latest sexual dysfunction news and features for those working in and with pharma, biotech and healthcare.

FDA panel backs Sprout Pharma's 'female Viagra'

The panel voted by 18 to 6 that the drug - called flibanserin - should be approved to treat hypoactive sexual desire disorder (HSDD) in pre-menopausal women, opening the door for a ... However, the committee said that given the intended use of the drug

Latest news

Lundbeck launches Brintellix in first EU market

Clinical trial results suggest Brintellix is at least as effective as Lexapro in adult patients with major depressive disorders and is significantly less likely to cause sexual dysfunction, a common problem
Menarini to raise awareness of sexual dysfunction

The rugby player ambassadors of Menarini's sexual dysfunction campaign. Italian pharma company A. ... Menarini Farmaceutica Internazionale has launched a campaign to address poor awareness of sexual dysfunction in the UK.
Female sexual dysfunction therapy pipeline

Female sexual dysfunction (FSD) pertains to persistent or recurrent problems with sexual response or desire in women. ... Both physical and psychosocial factors may be implicated in sexual dysfunction, although the exact cause cannot always be identified.
Making a big splash

Whether you are treating heart disease or sexual dysfunction, the biggest competitor we face is often doing nothing.
It's all in the detail

Defined by specific diseases, eg, psoriasis, rheumatoid arthritis, erectile dysfunction, etc, these groups will often discuss the topic in an oblique way. ... For example, erectile dysfunction conversations are often around sexual self-confidence, which

More from news
Approximately 1 fully matching, plus 25 partially matching documents found.

Latest Intelligence

Deal Watch February 2017

Acquisition - business unit. 1, 045. EndoCeutics/ AMAG Pharmaceuticals. Intraros (prasterone), non-oestrogen product for postmenopausal atrophic vaginitis (FDA approved), female sexual dysfunction (phase III).

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Editorial Director – Medical Education: Neg

Senior/ Market Access Consultant, UK, HOME BASED, £50-60K: Excellent package

Account Director – Global Healthcare PR: Salary TBC

Senior Account Manager - Med Comms: Highly Competitive Salary &Benefits

Senior Account Manager / Account Director - Med Comms: Great salary and benefits

SENIOR MEDICAL WRITER IN ONCOLOGY: Up to £60, 000.00 pension bonus

Lead Medical Copywriter, Healthcare Brand Communications, London: Excellent package

Account Director: Negotiable

Director Healthcare PR Communications: Salary TBC

Scientific Team Lead: Competitive Salary

Scientific Director – Medical Communications - New York or Remot...: $100000 - $150000

Senior Medical Writer (Remote Working): Competitive Salary Offered

Chief Medical Writer, Medical Communications, London, up to £90K...: up to £90K

Scientific Director: Highly Competitive Salary &Benefits

Director – Head of Public Affairs: Neg

Senior Account Director development role to Business Director, H...: Excellent package

Account Manager, Healthcare Communications: £32, 000 - £40, 000 benefits

Account Director - Digital: Great salary and benefits

Healthcare Advertising Account Manager / Senior AM / AD: Salary TBC

Experienced Editor, London, Medical Communications: Competitive package

Senior Account Executive – Medical Communications: Salary TBC

Project / Account Manager (Medical Education): Salary TBC

Account Manager- Manchester, Macclesfield or Glasgow: Negotiable

Account Director - Award Winning Healthcare Advertising Agency -...: £50000 - £68000

Medical Strategic Director, Healthcare Advertising Agency: Salary TBC

Subscribe to our email news alerts

PMHub

Add my company

Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

Redefining communications excellence: How to be heard in today’s multichannel, multistakeholder, multimedia world...
AstraZeneca: building a new ‘open innovation’ pharma company: The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
In conversation with Pfizer’s Erik Nordkamp: Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...